Spironolactone vs Hydrochlorothiazide
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Spironolactone (brand name Aldactone) and hydrochlorothiazide (HCTZ) are both diuretics used to manage fluid balance and blood pressure, but they belong to different classes and have complementary mechanisms that make them fundamentally different in clinical practice [1][2].
Spironolactone is a potassium-sparing diuretic and aldosterone antagonist. It works by blocking mineralocorticoid (aldosterone) receptors in the distal nephron, promoting sodium and water excretion while retaining potassium [1]. Beyond its diuretic effects, spironolactone has significant anti-androgenic properties, making it useful in conditions like acne, hirsutism, and female-pattern hair loss [1].
HCTZ is a thiazide diuretic that blocks the sodium-chloride cotransporter in the distal convoluted tubule [2]. It is one of the most widely prescribed first-line antihypertensive medications. Unlike spironolactone, HCTZ causes potassium loss, which is why the two drugs are often combined to balance their effects on potassium levels [1][2].
The most important clinical distinction: spironolactone preserves potassium (risk of hyperkalemia), while HCTZ depletes potassium (risk of hypokalemia) [1][2].
Spironolactone vs Hydrochlorothiazide: Side-by-side comparison
| Category | Spironolactone | Hydrochlorothiazide |
|---|---|---|
| Drug Class | Potassium-sparing diuretic / aldosterone antagonist | Thiazide diuretic |
| Brand Name | Aldactone | Microzide |
| FDA-Approved Uses | HF, hypertension, edema, primary aldosteronism | Hypertension, edema |
| Typical Dosage | 25-200 mg daily | 12.5-50 mg daily |
| Effect on Potassium | Retains potassium (risk of hyperkalemia) | Excretes potassium (risk of hypokalemia) |
| Anti-Androgen Effects | Yes (gynecomastia, menstrual changes) | No |
| Mortality Benefit in HF | Yes (RALES trial, 30% reduction) | No |
| Common Side Effects | Hyperkalemia, gynecomastia, dizziness | Hypokalemia, hyperuricemia, hyperglycemia |
| Metabolic Effects | Minimal | Raises glucose, uric acid, lipids |
| Generic Cost (30-day) | $4-$15 | $4-$10 |
Efficacy: How well does each drug work?
For hypertension, HCTZ is a well-established first-line agent with extensive cardiovascular outcome data [3]. Spironolactone is not typically a first-line antihypertensive but has emerged as a highly effective option for resistant hypertension (blood pressure uncontrolled on 3+ medications). The PATHWAY-2 trial demonstrated that spironolactone was significantly more effective than other add-on agents for treatment-resistant hypertension [4].
For heart failure, spironolactone has a critical role. The RALES trial showed that adding spironolactone 25 mg to standard therapy reduced mortality by 30% in patients with severe heart failure [5]. This landmark finding established mineralocorticoid receptor antagonists as essential heart failure therapy.
For liver cirrhosis with ascites, spironolactone is the first-line diuretic, often combined with furosemide. HCTZ has no significant role in cirrhotic ascites management [1]. For dermatological conditions (acne, hirsutism, female-pattern hair loss), spironolactone's anti-androgenic effects make it uniquely useful. HCTZ has no dermatological applications [1].
Side effects comparison
Spironolactone's most important side effect is hyperkalemia (elevated potassium), which can be dangerous and requires monitoring, especially in patients with kidney disease or those taking ACE inhibitors or ARBs [1]. Its anti-androgenic effects cause gynecomastia (breast enlargement) in up to 10% of men, breast tenderness, menstrual irregularities in women, and decreased libido [1]. Other side effects include dizziness, GI upset, and drowsiness.
HCTZ's side effects include hypokalemia (the opposite of spironolactone), hyperuricemia, hyperglycemia, hypercalcemia, photosensitivity, and dizziness [2]. HCTZ's metabolic effects (raising blood glucose, uric acid, and lipids) are clinically significant, particularly in patients with diabetes or gout [2][3].
When used together, spironolactone and HCTZ can partially offset each other's effects on potassium, though monitoring remains necessary [1][2].
Cost comparison
Both are available as inexpensive generics [6]. Generic spironolactone (25 mg, 50 mg, 100 mg) costs $4-$15 for a 30-day supply. Generic HCTZ (12.5 mg, 25 mg, 50 mg) costs $4-$10 per month. Both qualify for $4 generic programs. Insurance coverage is standard for both.
Convenience and dosing
Both are taken once daily as oral tablets, making convenience similar [1][2]. Spironolactone should be taken with food to improve absorption and reduce GI side effects [1]. HCTZ is typically taken in the morning.
Spironolactone requires more frequent lab monitoring, particularly potassium levels and kidney function, especially when initiated or when doses change [1]. HCTZ requires periodic electrolyte checks but generally less intensive monitoring.
Which is right for you?
HCTZ is the standard first-line choice for uncomplicated hypertension, supported by decades of cardiovascular outcome data [2][3].
Spironolactone is preferred for resistant hypertension, heart failure (where it reduces mortality), liver cirrhosis with ascites, primary aldosteronism, and dermatological conditions requiring anti-androgen therapy [1][4][5]. In men, the risk of gynecomastia may favor eplerenone (a more selective mineralocorticoid antagonist) as an alternative.
This information is for educational purposes only and does not constitute medical advice. Consult your healthcare provider to determine which medication is appropriate for your condition.
Frequently asked questions
References
- [Regulatory] Aldactone (spironolactone) prescribing information. Pfizer. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/012151s079lbl.pdf Accessed 2026-02-28.
- [Regulatory] Microzide (hydrochlorothiazide) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/040735s007lbl.pdf Accessed 2026-02-28.
- [Regulatory] ALLHAT Collaborative Group. Major outcomes in high-risk hypertensive patients (ALLHAT). JAMA. 2002;288(23):2981-2997. https://doi.org/10.1001/jama.288.23.2981 Accessed 2026-02-28.
- [Regulatory] Williams B, et al. Spironolactone versus placebo, bisoprolol, and doxazosin for resistant hypertension (PATHWAY-2). Lancet. 2015;386(10008):2059-2068. https://doi.org/10.1016/S0140-6736(15)00257-3 Accessed 2026-02-28.
- [Regulatory] Pitt B, et al. Effect of spironolactone on morbidity and mortality in severe heart failure (RALES). N Engl J Med. 1999;341(10):709-717. https://doi.org/10.1056/NEJM199909023411001 Accessed 2026-02-28.
- [Observational] GoodRx. Current pricing for generic spironolactone and HCTZ. https://www.goodrx.com/ Accessed 2026-02-28.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: